These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11563631)

  • 1. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
    Mattila PM; Röyttä M; Lönnberg P; Marjamäki P; Helenius H; Rinne JO
    Acta Neuropathol; 2001 Aug; 102(2):160-6. PubMed ID: 11563631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A post-mortem study on striatal dopamine receptors in Parkinson's disease.
    Rinne JO; Laihinen A; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1991 Aug; 556(1):117-22. PubMed ID: 1834312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
    Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
    Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
    Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.
    Langlais PJ; Thal L; Hansen L; Galasko D; Alford M; Masliah E
    Neurology; 1993 Oct; 43(10):1927-34. PubMed ID: 8105420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease.
    Mattila PM; Röyttä M; Torikka H; Dickson DW; Rinne JO
    Acta Neuropathol; 1998 Jun; 95(6):576-82. PubMed ID: 9650749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
    Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
    J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease.
    Griffiths PD; Perry RH; Crossman AR
    Neurosci Lett; 1994 Mar; 169(1-2):68-72. PubMed ID: 8047295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD.
    Kemppainen N; Ruottinen H; Nâgren K; Rinne JO
    Neurology; 2000 Jul; 55(2):205-9. PubMed ID: 10908891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic dysfunction in diseases with Lewy bodies.
    Tiraboschi P; Hansen LA; Alford M; Sabbagh MN; Schoos B; Masliah E; Thal LJ; Corey-Bloom J
    Neurology; 2000 Jan; 54(2):407-11. PubMed ID: 10668703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
    Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.
    Turjanski N; Lees AJ; Brooks DJ
    Neurology; 1997 Sep; 49(3):717-23. PubMed ID: 9305330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
    Pierot L; Desnos C; Blin J; Raisman R; Scherman D; Javoy-Agid F; Ruberg M; Agid Y
    J Neurol Sci; 1988 Sep; 86(2-3):291-306. PubMed ID: 2975699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of dopamine receptors in cholinergic motoneurons of the hypoglossal nucleus in a 6-OHDA-induced Parkinson's disease rat model.
    Zhou L; Wang ZY; Lian H; Song HY; Zhang YM; Zhang XL; Fan RF; Zheng LF; Zhu JX
    Biochem Biophys Res Commun; 2014 Sep; 452(3):560-6. PubMed ID: 25172664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
    Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
    Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.
    Court JA; Lloyd S; Thomas N; Piggott MA; Marshall EF; Morris CM; Lamb H; Perry RH; Johnson M; Perry EK
    Neuroscience; 1998 Nov; 87(1):63-78. PubMed ID: 9722142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease.
    Joyce JN; Murray AM; Hurtig HI; Gottlieb GL; Trojanowski JQ
    Neuropsychopharmacology; 1998 Dec; 19(6):472-80. PubMed ID: 9803423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes.
    Svensson AL; Warpman U; Hellström-Lindahl E; Bogdanovic N; Lannfelt L; Nordberg A
    Neurosci Lett; 1997 Aug; 232(1):37-40. PubMed ID: 9292886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.